Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE—famotidine or rebamipide in comparison by endoscopy)
- 231 Downloads
Nonsteroidal anti-inflammatory drugs (NSAIDs) and Helicobacter pylori infection are major causes of gastric mucosal lesions. In Japan, histamine-2 receptor antagonists are frequently prescribed, but the literature regarding their efficacy is limited. In this study, we compare the effects of famotidine and rebamipide on NSAID-associated gastric mucosal lesions using upper gastrointestinal endoscopy.
This study examined 112 patients taking NSAIDs for either gastric hemorrhage or erosion. Before treat-ment, the patients were assessed by endoscopy. Using blind randomization, patients were divided into two groups: group F (famotidine, 20 mg/day) and group R (rebamipide, 300 mg/day). Efficacy was examined 4 weeks later using endoscopy.
After treatment, the Lanza score decreased significantly in group F (P < 0.001) but not in group R (P = 0.478). The change in the Lanza score in group F was significantly greater (P = 0.002) than that in group R.
Famotidine was superior to rebamipide in treating NSAID-associated mucosal lesions.
Key wordsfamotidine rebamipide randomized study mucosal lesion NSAID
Unable to display preview. Download preview PDF.
- 1.Research Team for the Development of Guidelines for Evidence-Based Gastric Ulcer Diagnosis, Guideline for Clinical Practice of Gastric Ulcer Based on EBM (in Japanese with English abstract). Jiho 2003;7–14Google Scholar
- 8.Funatsu, T, Chono, K, Hirata, T, Keto, Y, Kimoto, A, Sasamata, M 2004The possible role of gastric acid against non-steroidal anti-inflammatory drugs-induced gastric microcirculatory disturbance in ratsJpn Pharmacol Ther3242934Google Scholar
- 11.Keto, Y, Funatsu, T, Hirata, T, Toyama, T, Sudoh, K, Sasamata, M 2003Inhibitory effects of famotidine on NSAIDs and bisphosphonate-induced mucosal lesions in ratsJpn Pharmacol Ther3148593Google Scholar
- 12.Raskin, JB, White, RH, Jackson, JE, Weaver, AL, Tindall, EA, Leis, RB, et al. 1991Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimensAnn Intern Med115195200Google Scholar
- 14.Bocanegra, TS, Weaver, AL, Tindall, EA, Sikes, DH, Ball, JA, Wallemark, CB, et al. 1998Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study GroupJ Rheumatol25160211PubMedGoogle Scholar
- 19.Naito, Y, Yoshikawa, T, Iinuma, S, Yagi, N, Matsuyama, K, Boku, Y, et al. 1998Rebamipide protects against indomethacin-induced mucosal lesion in healthy volunteers in a double-blind, placebo-controlled studyDig Dis Sci43839Google Scholar
- 20.Hawkey, CJ, Karrasch, JA, Szczepanski, L, Walker, DG, Barkun, A, Swannell, AJ, et al. 1998Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study GroupN Engl J Med33872734PubMedCrossRefGoogle Scholar
- 22.Miyake, K, Ueki, N, Suzuki, K, Shinji, Y, Kusunoki, M, Hiratsuka, T, et al. 2005Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidineAliment Pharmacol Ther216772PubMedCrossRefGoogle Scholar
- 23.Kitagami, K, Oku, K, Umemoto, N, Mizokami, Y, Shiozama, K, Yamana, S, et al. 1993Clinical study of rebamipide for NSAIDs induced gastritisJ Adult Dis23147788Google Scholar
- 24.Matsuhisa, T, Hayama, T, Nakamura, H, Yoshino, S, Yamada, N 1998Clinical usefulness of rebamipide against symptoms, gastric lesions and histological gastritis caused by long-term administration of NSAIDs in patients with rheumatoid arthritisGastroenterology (Tokyo)2711830Google Scholar